Clinical outcomes and pathological characteristics of immunoglobulin G4-related ophthalmic disease versus orbital inflammatory pseudotumor
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background/Aims: This study investigated the clinical and pathological features of immunoglobulin G4 (IgG4)-related ophthalmic disease. To clarify the features, we compared IgG4-related ophthalmic disease and orbital inflammatory pseudotumor. Methods: We retrospectively reviewed the medical records of 103 patients who were initially diagnosed with orbital inflammatory pseudotumor, and identified 16 cases in which the diagnosis was based on surgical biopsy and for which data in medical records were sufficient for analysis. Immunohistochemical staining of pathological specimens for IgG and IgG4 was performed. Finally, six of IgG4-related ophthalmic disease patient and 10 of orbital inf lammatory pseudotumor patient were analyzed. Results: The IgG4-related ophthalmic disease group had more IgG4-positive plasma cells and a higher IgG4/IgG plasma cell ratio than the orbital inflammatory pseudotumor group. Collagenous fibrosis and lacrimal gland involvement were significantly more frequent in the IgG4-related ophthalmic disease group. Dense lymphocyte infiltration, obliterative phlebitis, and bilateral lesions were more frequent in IgG4-related ophthalmic disease, but the differences were not significant. The recurrence-free period was shorter in the IgG4-related ophthalmic disease group (p = 0.035). Conclusions: The location of the lesion (lacrimal gland), count and ratio of IgG4-positive plasma cells, and collagenous fibrosis aid the diagnosis of IgG4-related ophthalmic disease in patients with idiopathic orbital mass-like lesions. In addition, maintenance therapy should be considered in patients with IgG4-related ophthalmic disease to prevent recurrence.
Abstract
Background/Aims: This study investigated the clinical and pathological features of immunoglobulin G4 (IgG4)-related ophthalmic disease. To clarify the features, we compared IgG4-related ophthalmic disease and orbital inflammatory pseudotumor. Methods: We retrospectively reviewed the medical records of 103 patients who were initially diagnosed with orbital inflammatory pseudotumor, and identified 16 cases in which the diagnosis was based on surgical biopsy and for which data in medical records were sufficient for analysis. Immunohistochemical staining of pathological specimens for IgG and IgG4 was performed. Finally, six of IgG4-related ophthalmic disease patient and 10 of orbital inf lammatory pseudotumor patient were analyzed. Results: The IgG4-related ophthalmic disease group had more IgG4-positive plasma cells and a higher IgG4/IgG plasma cell ratio than the orbital inflammatory pseudotumor group. Collagenous fibrosis and lacrimal gland involvement were significantly more frequent in the IgG4-related ophthalmic disease group. Dense lymphocyte infiltration, obliterative phlebitis, and bilateral lesions were more frequent in IgG4-related ophthalmic disease, but the differences were not significant. The recurrence-free period was shorter in the IgG4-related ophthalmic disease group (p = 0.035). Conclusions: The location of the lesion (lacrimal gland), count and ratio of IgG4-positive plasma cells, and collagenous fibrosis aid the diagnosis of IgG4-related ophthalmic disease in patients with idiopathic orbital mass-like lesions. In addition, maintenance therapy should be considered in patients with IgG4-related ophthalmic disease to prevent recurrence.
참고문헌 (15)
- Stone JH, "IgG4-related disease", N Engl J Med, 366, pp.539~551 (2012)
- Hamano H, "High serum IgG4concentrations in patients with sclerosing pancreatitis", N Engl J Med, 344, pp.732~738 (2001)
- Kamisawa T, "A new clinicopathological entity of IgG4-related autoimmune disease", J Gastroenterol, 38, pp.982~984 (2003)
- Deshpande V, "Consensus statement on the pathology of IgG4-related disease", Mod Pathol, 25, pp.1181~1192 (2012)
- Khosroshahi A, "International consensus guidance statement on the management and treatment of IgG4-related disease", Arthritis Rheumatol, 67, pp.1688~1699 (2015)
- Umehara H, "Comprehensive diagnostic criteria for IgG4-related disease(IgG4-RD), 2011", Mod Rheumatol, 22, pp.21~30 (2012)
- Kubota T, "Orbital IgG4-related disease : clinical features and diagnosis", ISRN Rheumatol, 2012, pp.412896~ (2012)
- Lee JH, "Radiotherapy with or without surgery for patients with idiopathic sclerosing orbital inflammation refractory or intolerant to steroid therapy", Int J Radiat Oncol Biol Phys, 84, pp.52~58 (2012)
- Della-Torre E, "Immunology of IgG4-related disease", Clin Exp Immunol, 181, pp.191~206 (2015)
- Sato Y, "IgG4-related disease : historical overview and pathology of hematological disorders", Pathol Int, 60, pp.247~258 (2010)
- Goto H, "Diagnostic criteria for IgG4-related ophthalmic disease", Jpn J Ophthalmol, 59, pp.1~7 (2015)
- Sa HS, "IgG4-related disease in idiopathic sclerosing orbital inflammation", Br J Ophthalmol, 99, pp.1493~1497 (2015)
- Song YS, "Ocular adnexal IgG4-related disease : CT and MRI findings", Br J Ophthalmol, 97, pp.412~418 (2013)
- Wallace ZS, "IgG4-related disease : clinical and laboratory features in one hundred twenty-five patients", Arthritis Rheumatol, 67, pp.2466~2475 (2015)
- Go H, "Ocular adnexal IgG4-related disease : comparative analysis with mucosa-associated lymphoid tissue lymphoma and other chronic inflammatory conditions", Histopathology, 60, pp.296~312 (2012)